"Your health and safety are always our top priority. To help you protect yourself and your loved ones, we’ve gathered the most important information and guidance on the coronavirus and COVID-19. Go to our website. You have many ways to get care without leaving the comfort of your home - including an e-visit, phone, video appointments, and email. This allows you to still get great care while helping to address the community spread of COVID-19. If you’re concerned about your specific health condition, call 1-833-KP4CARE (1-833-574-2273) (TTY 711) to talk to a licensed care provider 24/7. For answers to your general questions about COVID-19, call our new information line for Kaiser Permanente members at 1-877-813-7297."

During the past decade, Kaiser Permanente-San Diego Mission conducted 69 clinical trials. In the 10-year time frame, 69 clinical trials started and 51 clinical trials were completed, i.e. on average, 73.9% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 32 clinical trials were completed. i.e. 213.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente-San Diego Mission" #1 sponsor was "National Cancer Institute (NCI)" with 67 trials, followed by "SWOG Cancer Research Network" with 24 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "Children's Oncology Group" with 4 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente-San Diego Mission" #1 collaborator was "National Cancer Institute (NCI)" with 40 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator and "NCIC Clinical Trials Group" with 4 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente-San Diego Mission" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Recurrent Breast Carcinoma" (7 trials), "Stage IV Cutaneous Melanoma AJCC v6 and v7" (6 trials) and "Stage IV Lung Cancer AJCC v8" (5 trials). Many other conditions were trialed in "Kaiser Permanente-San Diego Mission" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente-San Diego Mission" are "Drug" (84 trials), "Other" (80 trials), "Biological" (53 trials), "Procedure" (27 trials) and "Radiation" (6 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (55 trials), "Quality-of-Life Assessment" (26 trials), "Biospecimen Collection" (15 trials), "Nivolumab" (15 trials) and "Computed Tomography" (14 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente-San Diego Mission" are 92 trials for "All" genders and 15 trials for "Female" genders.

Currently, there are NaN active trials in "Kaiser Permanente-San Diego Mission". undefined are not yet recruiting, 19 are recruiting, 55 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Kaiser Permanente-San Diego Mission, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente-San Diego Mission, 0 "Phase 1" clinical trials were conducted, 49 "Phase 2" clinical trials and 58 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".